Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class ASSE: 688266

Report for Q3 2025

Oct 31, 2025 · Issued by Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class A via Shanghai Stock Exchange

Report for Q3 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment